Recombinant Human CCL5
- 货号：EPT210
- 价格：￥1,404.00 元
- 点击：736
产品介绍
基本信息
| 规格 | 10ug |
|---|---|
| 表达宿主 | E.coli |
| 标签 | NA |
物理性质
| 分子量 | 7.8 KDa |
|---|---|
| 表观分子量 | 9-12 KDa, reducing conditions |
| 形态 | Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
| 纯度 | Greater than 95% as determined by reducing SDS-PAGE. |
活性与内毒素
| 内毒素水平 | Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. |
|---|
储存与运输
| 溶解方法 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
|---|---|
| 储存方法 | Lyophilized protein should be stored at < -20°C, though stable at room temperature for 3 weeks. Reconstituted protein solution can be stored at 4-7°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |
| 运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below. |
详细说明
| 背景说明 | Human Chemokine (C-C Motif) Ligand 5 (CCL5) plays an active role in recruiting leukocytes into inflammatory sites. CCL5 is secreted by many cell types at inflammatory sites and it exerts a wide range of activities through the receptors CCR1, CCR3, CCR4, and CCR5. N-Terminal truncated CCL5/RANTES, Met-RANTES, and amino-oxypentane (AOP)-RANTES exhibit antagonist or partial agonist functions on their receptors. CCL5/RANTES attracts different subtypes of leukocytes into inflamed tissue and intervenes in a wide range of allergic and autoimmune diseases. |
|---|
相关产品:
| 产品名称 | 点击数 |
|---|---|
| HDV 丁肝 | 1719 |
| 伤寒抗原 | 1515 |
| Syphilis 梅毒抗原抗体 | 1589 |
| A型产气荚膜梭菌a毒素蛋白 | 1525 |
| Clonorchiasis 肝吸虫 | 1354 |
| Schistosoma 血吸虫 | 1398 |
| β内酰胺受体 | 1350 |
| cProg犬孕酮 | 1469 |
| 犬钩端螺旋体抗原 | 1959 |
| 弓形虫抗原 | 1968 |
| FHV-I猫疱疹I型抗原 | 2145 |
| FIV猫艾滋抗原 | 2086 |
| 包虫 | 2207 |
| 犬瘟热重组抗原 Canine Distemper Virus Antigen | 1152 |
| Recombinant Human IGFBP-5 (C-6His) | 400 |
| Recombinant 2019-nCoV NSP10 (N-6His) | 382 |
| Recombinant 2019-nCoV Guanine-N7_meth (N-6His) | 443 |
| Recombinant Human EGF | 835 |
| Recombinant Human TGF-beta 1 | 850 |
| Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) | 655 |